Some Like it Hot: Cardioprotective Effect of Curcumin in Chronic Kidney Disease

作者: Elena N. Dedkova

DOI: 10.1007/S10557-015-6586-5

关键词:

摘要: Chronic kidney disease (CKD) is a progressive loss of structure (i.e., proteinuria, abnormal urinary sediment, abnormalities on imaging studies) and function glomerular filtration rate (GFR) <60 mL/min per 1.73 m) over period 3 months or longer which leads to accumulation water, waste, toxic substances in the body that are normally excreted by [1]. The presence CKD confers markedly increased risk cardiovascular disease, fact patients with die primarily from complications rather than end-stage renal failure [2, 3]. plays central role electrolyte balance, volume, blood pressure regulation; all these parameters have significant impact health [4]. If kidneys fail work properly, fluid builds up quickly lungs heart leading hypervolemia. This increases workload could lead chronic due volumeoverload venous low systematic arterial [5]. turn reduces net perfusion pressure, further reducing stimulating many neurohumoral factors such as renin–angiotensin–aldosterone system (RAAS), sympathetic nervous system, including adrenals, arginine–vasopressin maintain supply [6]. In addition, metabolic disturbances accelerate atherosclerotic process causing vascular calcification stiffness overload. Histopathological studies indicate capillary density reduced hypertrophied myocardium, pronounced interstitial fibrosis dominant feature CKD-associated structural myocardial remodeling Furthermore, higher rates arrhythmias sudden death observed shifts balance substrate. Therefore, primary secondary prevention future events remains an important clinical goal. There four types traditional medicine used CKD: 1) angiotensin-converting enzyme inhibitors (ACEIs); 2) angiotensin II receptor blockers/antagonists (ARBs); 3) beta-blockers; 4) statins. Unfortunately, drugs therapies currently for treatment rarely effects associated numerous negative side emerging search alternative strategies prevent cardiac CKD. study Cecilia Zazueta’s group sought determine effect curcumin treating dysfunction rats established [7]. their previous study, they reported pre-treatment subjected subtotal nephrectomy, prevented increase systolic (SBP), preserved * Elena N. Dedkova elena_dedkova@rush.edu

参考文章(23)
R. Hajhosseiny, K. Khavandi, D. J. Goldsmith, Cardiovascular disease in chronic kidney disease: untying the Gordian knot International Journal of Clinical Practice. ,vol. 67, pp. 14- 31 ,(2013) , 10.1111/J.1742-1241.2012.02954.X
Sauri Hernández-Reséndiz, Francisco Correa, Wylly R. García-Niño, Mabel Buelna-Chontal, Francisco J. Roldán, Ixchel Ramírez-Camacho, Carolina Delgado-Toral, Roxana Carbó, José Pedraza-Chaverrí, Edilia Tapia, Cecilia Zazueta, Cardioprotection by Curcumin Post-Treatment in Rats with Established Chronic Kidney Disease Cardiovascular Drugs and Therapy. ,vol. 29, pp. 111- 120 ,(2015) , 10.1007/S10557-015-6581-X
Dania Akbik, Maliheh Ghadiri, Wojciech Chrzanowski, Ramin Rohanizadeh, Curcumin as a wound healing agent. Life Sciences. ,vol. 116, pp. 1- 7 ,(2014) , 10.1016/J.LFS.2014.08.016
J.L. Dyer, S. Zafar Khan, J.G. Bilmen, S.R. Hawtin, M. Wheatley, M.-ul-H. Javed, F. Michelangeli, Curcumin: a new cell-permeant inhibitor of the inositol 1,4,5-trisphosphate receptor. Cell Calcium. ,vol. 31, pp. 45- 52 ,(2002) , 10.1054/CECA.2001.0259
Ajay Goel, Ajaikumar B. Kunnumakkara, Bharat B. Aggarwal, Curcumin as “Curecumin”: From kitchen to clinic Biochemical Pharmacology. ,vol. 75, pp. 787- 809 ,(2008) , 10.1016/J.BCP.2007.08.016
Andrew S Levey, Paul E De Jong, Josef Coresh, Meguid El Nahas, Brad C Astor, Kunihiro Matsushita, Ron T Gansevoort, Bertram L Kasiske, Kai-Uwe Eckardt, The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report Kidney International. ,vol. 80, pp. 17- 28 ,(2011) , 10.1038/KI.2010.483
Subash C. Gupta, Sahdeo Prasad, Ji Hye Kim, Sridevi Patchva, Lauren J. Webb, Indira K. Priyadarsini, Bharat B. Aggarwal, Multitargeting by curcumin as revealed by molecular interaction studies Natural Product Reports. ,vol. 28, pp. 1937- 1955 ,(2011) , 10.1039/C1NP00051A
Sharmini Selvarajah, Cuno S. P. M. Uiterwaal, Jamaiyah Haniff, Yolanda van der Graaf, Frank L. J. Visseren, Michiel L. Bots, , Renal impairment and all-cause mortality in cardiovascular disease: effect modification by type 2 diabetes mellitus European Journal of Clinical Investigation. ,vol. 43, pp. 198- 207 ,(2013) , 10.1111/ECI.12035
Francisco Correa, Mabel Buelna-Chontal, Sauri Hernández-Reséndiz, Wylly R. García-Niño, Francisco J. Roldán, Virgilia Soto, Alejandro Silva-Palacios, Alejandra Amador, José Pedraza-Chaverrí, Edilia Tapia, Cecilia Zazueta, Curcumin maintains cardiac and mitochondrial function in chronic kidney disease Free Radical Biology and Medicine. ,vol. 61, pp. 119- 129 ,(2013) , 10.1016/J.FREERADBIOMED.2013.03.017
Chunlai Zeng, Peng Zhong, Yunjie Zhao, Karvannan Kanchana, Yali Zhang, Zia A. Khan, Subrata Chakrabarti, Lianpin Wu, Jingying Wang, Guang Liang, Curcumin protects hearts from FFA-induced injury by activating Nrf2 and inactivating NF-κB both in vitro and in vivo. Journal of Molecular and Cellular Cardiology. ,vol. 79, pp. 1- 12 ,(2015) , 10.1016/J.YJMCC.2014.10.002